Mónica L Fanarraga

Prof. Dr. Mónica L Fanarraga

Universidad de Cantabria – IDIVAL, Santander, Spain
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2003 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
SDSean W. Deacon
Sean W. Deacon
ASAnna S. Serpinskaya
Anna S. Serpinskaya
PVPatricia S. Vaughan
Patricia S. Vaughan
MFMónica L Fanarraga
Mónica L Fanarraga
IVIsabelle Vernos
Isabelle Vernos
VGVladimir I. Gelfand
Vladimir I. Gelfand
Kinesin II is a heterotrimeric plus end–directed microtubule motor responsible for the anterograde movement of organelles in various cell types. Despite substantial literature concerning the types of organelles that kinesin II transports, the question of how this motor associates with cargo organelles remains unanswered. To address this question, we have used Xenopus laevis melanophores as a model system. Through analysis of kinesin II–mediated melanosome motility, we have determined that the dynactin complex, known as an anchor for cytoplasmic dynein, also links kinesin II to organelles. Biochemical data demonstrates that the putative cargo-binding subunit of Xenopus kinesin II, Xenopus kinesin II–associated protein (XKAP), binds directly to the p150Glued subunit of dynactin. This interaction occurs through aa 530–793 of XKAP and aa 600–811 of p150Glued. These results reveal that dynactin is required for transport activity of microtubule motors of opposite polarity, cytoplasmic dynein and kinesin II, and may provide a new mechanism to coordinate their activities.

1 August 1992 in Nature
Verified
Journal Article
Closed access
PDF file
ASArmin Schneider
Armin Schneider
PMPaul Montague
Paul Montague
IGIan Griffiths
Ian Griffiths
MFMónica L Fanarraga
Mónica L Fanarraga
PKPeter Kennedy
Peter Kennedy
KNKlaus-Armin Nave
Klaus-Armin Nave

1 May 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
NINerea Iturrioz-Rodríguez
Nerea Iturrioz-Rodríguez
Miguel A. Correa-DuarteMiguel A. Correa-Duarte
Miguel A. Correa-Duarte
MFMónica L Fanarraga
Mónica L Fanarraga
The implementation of nanotechnology in medicine has opened new research horizons particularly in the field of therapeutic delivery. Mesoporous silica particles have emerged as biocompatible drug delivery systems with an enormous potential in the treatment of cancer among many other pathologies. In this review, we focus on the unique properties of these particles as chemotherapy delivery carriers. Here, we summarize the general characteristics of these nanomaterials – including their physicochemical properties and customizable surfaces – different stimuli that can be used to trigger targeted drug release, biocompatibility and finally, the drawbacks of these types of nanomaterials, highlighting some of the most important features of mesoporous silica nanoparticles in drug delivery.

1 August 2001 in Journal of Structural Biology
Verified
Journal Article
Closed access
MFMónica L Fanarraga
Mónica L Fanarraga
JAJesus Avila
Jesus Avila
AGAlicia Guasch
Alicia Guasch
MCMiquel Coll
Miquel Coll
JZJuan Carlos Zabala
Juan Carlos Zabala

1 January 2017 in Biomaterials
Verified
Journal Article
Open access
BSBeatriz Sanz
Beatriz Sanz
MCM. Pilar Calatayud
M. Pilar Calatayud
TTTeobaldo E. Torres
Teobaldo E. Torres
MFMónica L Fanarraga
Mónica L Fanarraga
MIM. Ricardo Ibarra
M. Ricardo Ibarra
Gerardo F. GoyaGerardo F. Goya
Gerardo F. Goya
Magnetic hyperthermia is a new type of cancer treatment designed for overcoming resistance to chemotherapy during the treatment of solid, inaccessible human tumors. The main challenge of this technology is increasing the local tumoral temperature with minimal side effects on the surrounding healthy tissue. This work consists of an in vitro study that compared the effect of hyperthermia in response to the application of exogenous heating (EHT) sources with the corresponding effect produced by magnetic hyperthermia (MHT) at the same target temperatures. Human neuroblastoma SH-SY5Y cells were loaded with magnetic nanoparticles (MNPs) and packed into dense pellets to generate an environment that is crudely similar to that expected in solid micro-tumors, and the above-mentioned protocols were applied to these cells. These experiments showed that for the same target temperatures, MHT induces a decrease in cell viability that is larger than the corresponding EHT, up to a maximum difference of approximately 45% at T = 46 °C. An analysis of the data in terms of temperature efficiency demonstrated that MHT requires an average temperature that is 6 °C lower than that required with EHT to produce a similar cytotoxic effect. An analysis of electron microscopy images of the cells after the EHT and MHT treatments indicated that the enhanced effectiveness observed with MHT is associated with local cell destruction triggered by the magnetic nano-heaters. The present study is an essential step toward the development of innovative adjuvant anti-cancer therapies based on local hyperthermia treatments using magnetic particles as nano-heaters.

Verified
Journal Article
Open access
PDF file
AFAndrés Fernández-Borbolla
Andrés Fernández-Borbolla
LGLorena Garcia García
Lorena Garcia García
MFMónica L Fanarraga
Mónica L Fanarraga
Nanoencapsulation has become a recent advancement in drug delivery, enhancing stability, bioavailability, and enabling controlled, targeted substance delivery to specific cells or tissues. However, traditional nanoparticle delivery faces challenges such as a short circulation time and immune recognition. To tackle these issues, cell membrane-coated nanoparticles have been suggested as a practical alternative. The production process involves three main stages: cell lysis and membrane fragmentation, membrane isolation, and nanoparticle coating. Cell membranes are typically fragmented using hypotonic lysis with homogenization or sonication. Subsequent membrane fragments are isolated through multiple centrifugation steps. Coating nanoparticles can be achieved through extrusion, sonication, or a combination of both methods. Notably, this analysis reveals the absence of a universally applicable method for nanoparticle coating, as the three stages differ significantly in their procedures. This review explores current developments and approaches to cell membrane-coated nanoparticles, highlighting their potential as an effective alternative for targeted drug delivery and various therapeutic applications.